Xiaodi Han

Xiaodi Han, Spinal Cord Reconstruction, meningeoma, hypophysoma, glioma, craniopharyngioma,

#12 Tiantan Nanli, Dongcheng District

Speciality: Spinal Cord Reconstruction, meningeoma, hypophysoma, glioma, craniopharyngioma,

Languages: Chinese

Degree: MD

About - Xiaodi Han

Professor, Doctoral Advisor, Chief Scientist of Targeted Therapy of Glioma, Director of the Neurosurgical Department, Reviewer of Journal of Neuroscience Research, Member of Evaluation Committee of Natural Science Foundation of China (NSFC).

Dr. Xiaodi Han graduated from Shanghai Medical University (now merged with Fudan University) in 1992. In the same year, he came to work at the Neurosurgery Department of Beijing Tiantan Hospital. There, he studied under Professor Jizhong Zhao, and participated in many important research projects of Beijing. He is also the editor of many neurosurgery books. Since working at the Neurosurgery Department of Beijing Tiantan Hospital, he was in charge of comprehensive treatment of glioma and various kinds of neurosurgical treatments. He has worked at Alfred Hospital, Melbourne, Australia, and Wichita State University, Kansas, America. Subsequently, he has worked at the Neurosurgery Department of University of Rochester Medical Center where he was responsible for post-graduate research specializing in stem cell treatment.

Currently, Dr. Xiaodi Han is the Director of Neurosurgery Center of Beijing Puhua International Hospital. He devotes himself to clinical work and teaching research of stem cell treatment for neurosurgical diseases. His creative “spinal cord reconstruction” surgery benefits hundreds of patients from all around the world. He is ingenious at surgical treatment and comprehensive postoperative treatment for glioma, which has brought him international recognition. In addition, he is a forerunner of stem cell targeted therapy of glioma research, both at home and overseas.

Areas of specialization: Spinal cord reconstruction, meningeoma, hypophysoma, glioma, craniopharyngioma, surgical treatment for glioma, immunological treatment for glioma, comprehensive postoperative treatment for glioma.